PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25024745-13	2014	In vitro treatment of CD90+ cells with Mocetinostat reversed myofibroblast phenotype as indicated by a decrease in alpha-Smooth muscle actin (alpha-SMA), Collagen III, and Matrix metalloproteinase-2 (MMP2).	mocetinostat	39-51	matrix metallopeptidase 2	Rattus norvegicus	172-198	
25024745-13	2014	In vitro treatment of CD90+ cells with Mocetinostat reversed myofibroblast phenotype as indicated by a decrease in alpha-Smooth muscle actin (alpha-SMA), Collagen III, and Matrix metalloproteinase-2 (MMP2).	mocetinostat	39-51	matrix metallopeptidase 2	Rattus norvegicus	200-204